Related Experiment Videos
[beta-Radiation exposure with (188)Re-labelled pharmaceuticals]
M Andreeff1, G Wunderlich, K Behge
1Nuklearmedizin, Universitätsklinikum Carl Gustav Carus, an der TU Dresden, Fetscherstr. 74, 01307 Dresden. Michael.Andreeff@klinikum-dresden.de
Nuklearmedizin. Nuclear Medicine
|June 22, 2005
Summary
Staff handling Rhenium-188 radiopharmaceuticals face significant skin radiation exposure, particularly radiochemists and physicians. Standard dosimeters underestimate the actual beta radiation dose (Hp(0.07)) to fingertips, posing a risk of exceeding regulatory limits.
Area of Science:
- Nuclear Medicine
- Radiation Oncology
- Radiopharmacy
Context:
- Increasing use of Rhenium-188 (188Re) radiopharmaceuticals in therapies.
- Need for accurate documentation of beta radiation exposure (Hp(0.07)) for healthcare staff under new regulations.
- Scarcity of data on beta radiation exposure during handling of 188Re-labelled agents.
Purpose:
- To determine the personal dose Hp(0.07) of the skin of the hands when handling 188Re radiopharmaceuticals.
- To identify specific tasks and personnel with high radiation exposure.
- To provide data for optimizing working conditions and ensuring compliance with radiation protection laws.
Summary:
- Thermoluminescence dosimeters (TLDs) on fingertips measured significantly higher beta radiation doses than official ring dosimeters or electronic personal dosimeters (EPDs).
- Radiochemists and physicians involved in the production and application of 188Re radiopharmaceuticals received the highest cumulative finger doses.
- The study highlights that standard dosimetry methods underestimate the true skin dose to the fingertips during 188Re therapies.
Impact:
- Findings indicate a substantial risk of exceeding the annual radiation limit of 500 mSv for staff, especially radiochemists and physicians.
- Emphasizes the need for revised radiation safety protocols and improved personal protective equipment for handling 188Re.
- Contributes crucial data for regulatory bodies and healthcare institutions to enhance radiation safety measures in nuclear medicine.